GSK-269984B is a novel EP1 receptor antagonist. References: Ostenfeld T, Beaumont C, Bullman J, Beaumont M, Jeffrey P. Human microdose evaluation of the novel EP1 receptor antagonist GSK269984A. Br J Clin Pharmacol. 2012 Dec;74(6):1033-44. doi: 10.1111/j.1365-2125.2012.04296.x. PubMed PMID: 22497298; PubMed Central PMCID: PMC3522817.

纯度：≥98%

CAS：892664-17-4